Difference between revisions of "Never Lose Your Xarelto Lawsuit Again"

Latest revision as of 12:47, 22 April 2018

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical organizations, such as the makers of Xarelto, possess a duty to make sure that their drugs are reasonably safe for use - and failure to do so may possibly be grounds for compensation. Our lawyers are functioning tough to get these hurt by the drug the compensation they're entitled to.

While bleeding is actually a widespread complication associated with anticoagulants, it has been alleged that Xarelto is more dangerous than traditional blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This means that, inside the event of an emergency, sufferers may possibly be at threat for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.

Should you or a loved one particular suffered a serious bleeding occasion after taking xarelto do's and don'ts, you may have legal recourse. For a lot more data, make contact with us these days to have your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for past and future health-related bills, lost wages, pain and suffering and, in circumstances of death, funeral costs. Additionally, they may be looking for punitive damages, which are normally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.

Visit this page for far more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.